Skip to main content
OpenTrials

Clinical trial condition

Bronchial Neoplasms

Explore clinical trials studying Bronchial Neoplasms. Study availability and eligibility vary by location and protocol.

5,289 public trials 1,200 recruiting studies
Refine in advanced search Browse all conditions

Bronchial Neoplasms trial results

Completed

Dose Individualization of Pemetrexed - IMPROVE-III

NCT03655834

Conditions
Adenoma, Bronchial Neoplasms, Carcinoma, Bronchogenic, +13 more
Locations
  • Jeroen Bosch Hospital 's-Hertogenbosch, Netherlands
  • Antoni van Leeuwenhoek Amsterdam, Netherlands
  • Maastricht University Medical centre Maastricht, Netherlands
  • Radboud university medical centre Nijmegen, Netherlands
View Trial Details
Completed

Metabolomic Analysis of Lung Cancer

NCT00263731

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations
  • James Graham Brown Cancer Center, University of Louisville Louisville, Kentucky, United States
View Trial Details
Completed

First-Line Treatment of A Comparison of 2 Treatments in Elderly Patients With Advanced NSCLC

NCT00456261

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Northeast Alabama Regional Medical Center Anniston, Alabama, United States
  • NEA Baptist Clinic Jonesboro, Arkansas, United States
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • Watson Clinic Center for Cancer Care and Research Lakeland, Florida, United States
View all 18 locations
View Trial Details
Completed

VX15/2503 in Combination With Avelumab in Advanced Non-small Cell Lung Cancer

NCT03268057

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +10 more
Locations
  • Highlands Oncology Group, PA Fayetteville, Arkansas, United States
  • University of California Los Angeles (UCLA) Los Angeles, California, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View Trial Details
Completed

A Study of the Safety, Tolerability and Pharmacokinetics of ABBV-368 as a Single Agent and Combination in Subjects With Locally Advanced or Metastatic Solid Tumors

NCT03071757

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +58 more
Locations
  • Moores Cancer Center at UC San Diego /ID# 201334 La Jolla, California, United States
  • University of California, Davis Comprehensive Cancer Center /ID# 201342 Sacramento, California, United States
  • Stanford University /ID# 206949 Stanford, California, United States
  • Yale University /ID# 207895 New Haven, Connecticut, United States
View all 27 locations
View Trial Details
Completed

Evaluate the Impact of Afatinib on Quality of Life and Symptom Burden of Greek Subjects With Advanced NSCLC in Routine Patient Care Settings

NCT02440854

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • University General Hospital of Evros Alexandroupoli, Greece
  • Chest Hospital of Athens "Sotiria" Athens, Greece
  • "Attikon" University General Hospital of Attica Haidari, Greece
  • University General Hospital of Heraklion Heraklion, Greece
View Trial Details
Completed

Study Of OX40 Agonist PF-04518600 Alone And In Combination With 4-1BB Agonist PF-05082566

NCT02315066

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +60 more
Locations
  • The Angeles Clinic And Research Institute, A Cedars-Sinai Affiliate Los Angeles, California, United States
  • Keck Hospital of USC Los Angeles, California, United States
  • LAC+USC Medical Center Los Angeles, California, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 30 locations
View Trial Details

Related conditions